Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging:: Multicenter study comparing MR and dual-phase spiral CT

被引:65
作者
Oudkerk, M [1 ]
Torres, CG
Song, B
König, M
Grimm, J
Fernandez-Cuadrado, J
de Beeck, BO
Marquardt, M
van Dijk, P
de Groot, JC
机构
[1] Univ Hosp Rotterdam, Daniel Hoed Canc Ctr, Dept Radiol, Rotterdam, Netherlands
[2] State Univ, NL-9700 RB Groningen, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
[4] West China Univ Med Sci, Univ Hosp 1, Chengdu, Peoples R China
[5] Nycomed Amersham, Oslo, Norway
[6] Ruhr Univ Clin, Bochum, Germany
[7] Univ Kiel, Kiel, Germany
[8] Hosp La Paz, Madrid, Spain
[9] Univ Hosp, Free Univ, Brussels, Belgium
关键词
computed tomography (CT); comparative studies; contrast media; liver neoplasms; diagnosis; magnetic resonance (MR);
D O I
10.1148/radiol.2232010318
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To evaluate whether mangafodipir trisodium (Mn-DPDP)- enhanced magnetic resonance (MR) imaging surpasses dual-phase spiral computed tomography (CT) in differentiating focal liver lesions. MATERIALS AND METHODS: One hundred forty-five patients who had or were suspected of having focal liver lesions were included in a multicenter study and underwent dual-phase spiral CT and enhanced MR imaging. Image interpretations performed by independent experienced radiologists were compared with the final diagnosis that was based on all available clinical information (including histopathologic findings in 77 patients) and that was determined with consensus. Differences in classifications by using either enhanced MR imaging or dual-phase spiral CT were analyzed with the McNemar test, and receiver operating characteristic (ROC) curves were used to compare the diagnostic performance of enhanced MR imaging and dual-phase spiral CT. RESULTS: Lesion classification was correct in 108 (74%) patients with enhanced MR imaging and in 83 (57%) with dual-phase spiral CT (P = .001). Lesions were correctly classified as either malignant or benign in 123 (85%) patients with enhanced MR imaging and in 98 (68%) with dual-phase spiral CT (P = .001). Classification of lesions as either hepatocellular or nonhepatocellular was correct in 130 (90%) patients with enhanced MR imaging and in 93 (64%) with dual-phase spiral CT (P = .001). These differences remained when analyses were restricted to histopathologically confirmed diagnoses. Comparison of the ROC curves illustrated that enhanced MR imaging performance surpassed that of dual-phase spiral CT. CONCLUSION: Mn-DPDP-enhanced MR imaging is superior to dual-phase spiral CT in classification of focal liver lesions. (C) RSNA, 2002.
引用
收藏
页码:517 / 524
页数:8
相关论文
共 30 条
[1]   Hepatocellular carcinoma: Evaluation with biphasic, contrast-enhanced, helical CT [J].
Baron, RL ;
Oliver, JH ;
Dodd, GD ;
Nalesnik, M ;
Holbert, BL ;
Carr, B .
RADIOLOGY, 1996, 199 (02) :505-511
[2]   Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging [J].
Coffin, CM ;
Diche, T ;
Mahfouz, AE ;
Alexandre, M ;
Caseiro-Alves, F ;
Rahmouni, A ;
Vasile, N ;
Mathieu, D .
EUROPEAN RADIOLOGY, 1999, 9 (03) :444-449
[3]   Liver-specific MR imaging contrast agents [J].
Hahn, PF ;
Saini, S .
RADIOLOGIC CLINICS OF NORTH AMERICA, 1998, 36 (02) :287-+
[4]   FOCAL LIVER-LESIONS - MR IMAGING WITH MN-DPDP - INITIAL CLINICAL-RESULTS IN 40 PATIENTS [J].
HAMM, B ;
VOGL, TJ ;
BRANDING, G ;
SCHNELL, B ;
TAUPITZ, M ;
WOLF, KJ ;
LISSNER, J .
RADIOLOGY, 1992, 182 (01) :167-174
[5]   THE MEANING AND USE OF THE AREA UNDER A RECEIVER OPERATING CHARACTERISTIC (ROC) CURVE [J].
HANLEY, JA ;
MCNEIL, BJ .
RADIOLOGY, 1982, 143 (01) :29-36
[6]   DUAL-PHASE HELICAL CT OF THE LIVER - VALUE OF ARTERIAL PHASE SCANS IN THE DETECTION OF SMALL (LESS-THAN-OR-EQUAL-TO-1.5-CM) MALIGNANT HEPATIC NEOPLASMS [J].
HOLLETT, MD ;
JEFFREY, RB ;
NINOMURCIA, M ;
JORGENSEN, MJ ;
HARRIS, DP .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1995, 164 (04) :879-884
[7]  
Imam K, 2000, Magn Reson Imaging Clin N Am, V8, P741
[8]  
Kane PA, 1997, ACTA RADIOL, V38, P650
[9]   Contrast agents for MR imaging of the liver: A clinical overview [J].
Mahfouz, AE ;
Hamm, B ;
Taupitz, M .
EUROPEAN RADIOLOGY, 1997, 7 (04) :507-513
[10]   Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP) [J].
Murakami, T ;
Baron, RL ;
Peterson, MS ;
Oliver, JH ;
Davis, PL ;
Confer, SR ;
Federle, MP .
RADIOLOGY, 1996, 200 (01) :69-77